Serum Homocysteine and Lipid Profile Alterations in Preeclampsia: A Case Control Study
International Journal of Drug Delivery Technology · 25.05.2026 · 16 (34s)
DOI: 10.25258/ijddt.16.34s.97 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, erschienen am 25.05.2026. Verfasst von Gaurav Rastogi und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Preeclampsia is a multisystem disorder of pregnancy characterized by hypertension and proteinuria after 20 weeks of gestation. Endothelial dysfunction and metabolic disturbances play a central role in its pathogenesis. Dyslipidemia and elevated serum homocysteine levels are considered important contributors to vascular injury in preeclampsia. Therefore, the present study aims to evaluate and correlate serum homocysteine levels with lipid profile parameters in patients with preeclampsia.
Methods
This case–control study was conducted in MMIMSR, Mullana, Ambala. A total of 76 pregnant women were enrolled, including 51 preeclamptic cases (Group A) and 25 age-matched normotensive controls (Group B). Preeclampsia was diagnosed according to ACOG criteria (BP ≥140/90 mmHg after 20 weeks with proteinuria). Serum homocysteine and lipid profile were estimated using standard biochemical methods. Statistical analysis was performed using independent t-test, chi-square test, and Pearson correlation.
Results
Mean serum homocysteine levels were significantly higher in preeclamptic women (39.87 ± 15.88 µmol/L) compared to controls (17.43 ± 9.98 µmol/L) (p < 0.001). Among lipid parameters, triglycerides (319.96 ± 106.47 mg/dL vs 211.75 ± 86.20 mg/dL) and VLDL (63.99 ± 21.29 mg/dL vs 42.35 ± 17.24 mg/dL) were significantly elevated in the test group (p = 0.001). No significant differences were observed in LDL, HDL, total cholesterol, and non-HDL cholesterol levels (p > 0.05).
Conclusion
Preeclamptic women exhibit significantly elevated homocysteine and abnormal lipid levels contribute to endothelial dysfunction, and may serve as useful biomarkers for early detection and risk assessment.
Zitieren
APA
Rastogi, G., Bhutani, K., & Chauhan, P. (2026). Serum Homocysteine and Lipid Profile Alterations in Preeclampsia: A Case Control Study. International Journal of Drug Delivery Technology, 16(34s). https://doi.org/10.25258/ijddt.16.34s.97
Vancouver
Rastogi G, Bhutani K, Chauhan P. Serum Homocysteine and Lipid Profile Alterations in Preeclampsia: A Case Control Study. International Journal of Drug Delivery Technology. 2026;16(34s). doi:10.25258/ijddt.16.34s.97
BibTeX
@article{Rastogi2026,
author = {Rastogi, Gaurav and Bhutani, Karanpreet and Chauhan, Parul},
title = {Serum Homocysteine and Lipid Profile Alterations in Preeclampsia: A Case Control Study},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {34s},
doi = {10.25258/ijddt.16.34s.97}
}
EUVIMED